ARX:ASX
Aroa Biosurgery Ltd
AU$ 0,48
0,00%
(0,00) 1D
16 de nov., 16:10:15 GMT+11 · AUD
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para ARX…
Valor de mercado
166,03 mi
Volume médio
265,00 mil
Volume
0,00
Índice P/L
45,80
Alto — 52 sem
AU$ 0,78
Baixo — 52 sem
AU$ 0,46
LPA
AU$ 0,01
Ações em circulação
345,90 mi
Nº de funcionários
261
Valor de mercado
166,03 mi
Volume médio
265,00 mil
Volume
0,00
Índice P/L
45,80
Alto — 52 sem
AU$ 0,78
Baixo — 52 sem
AU$ 0,46
LPA
AU$ 0,01
Ações em circulação
345,90 mi
Nº de funcionários
261
Notícias
De fontes da web e parceiros de notícias
Bloomberg.com
·
há 37 minutos
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
marketscreener.com
·
há 1 hora
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
Investing.com
·
há 1 hora
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
Traders Union
·
há 14 minutos
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Perfil
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Sobre Aroa Biosurgery Ltd